NO984644D0 - Non-dendritic spine peptide carrier - Google Patents
Non-dendritic spine peptide carrierInfo
- Publication number
- NO984644D0 NO984644D0 NO984644A NO984644A NO984644D0 NO 984644 D0 NO984644 D0 NO 984644D0 NO 984644 A NO984644 A NO 984644A NO 984644 A NO984644 A NO 984644A NO 984644 D0 NO984644 D0 NO 984644D0
- Authority
- NO
- Norway
- Prior art keywords
- dendritic spine
- peptide carrier
- peptide
- carrier
- dendritic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56977—HLA or MHC typing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/115—Paramyxoviridae, e.g. parainfluenza virus
- G01N2333/12—Mumps virus; Measles virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/35—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycobacteriaceae (F)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/44—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
- G01N2333/445—Plasmodium
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
- G01N2333/545—IL-1
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/555—Interferons [IFN]
- G01N2333/57—IFN-gamma
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96486—Metalloendopeptidases (3.4.24)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK39896 | 1996-04-03 | ||
PCT/DK1997/000146 WO1997038011A1 (en) | 1996-04-03 | 1997-04-03 | Non-dendritic backbone peptide carrier |
Publications (2)
Publication Number | Publication Date |
---|---|
NO984644D0 true NO984644D0 (en) | 1998-10-02 |
NO984644L NO984644L (en) | 1998-12-03 |
Family
ID=8093081
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO984644A NO984644L (en) | 1996-04-03 | 1998-10-02 | Non-dendritic spine peptide carrier |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0896582A1 (en) |
JP (1) | JP2001502658A (en) |
KR (1) | KR20000005429A (en) |
CN (1) | CN1215404A (en) |
AU (1) | AU704502B2 (en) |
CA (1) | CA2251464A1 (en) |
HU (1) | HUP9901254A3 (en) |
NO (1) | NO984644L (en) |
NZ (1) | NZ331596A (en) |
WO (1) | WO1997038011A1 (en) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6103239A (en) | 1996-08-09 | 2000-08-15 | Cel-Sci Corporation | Modified HGP-30 heteroconjugates, compositions and methods of use |
US6251866B1 (en) | 1997-08-05 | 2001-06-26 | Watson Laboratories, Inc. | Conjugates targeted to the interleukin-2 receptor |
JP2001523647A (en) * | 1997-11-18 | 2001-11-27 | メディカル ユニバーシティー オブ サウス カロライナ | Linear antigen support unit |
US7481999B2 (en) | 1998-05-05 | 2009-01-27 | Adherex Technologies, Inc. | Compounds and methods for modulating OB-cadherin-mediated function |
US6472367B1 (en) * | 1998-05-05 | 2002-10-29 | Adherex Technologies, Inc. | Compounds and methods for modulating OB-cadherin mediated cell adhesion |
US7060284B1 (en) | 1999-08-03 | 2006-06-13 | The Ohio State University | Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein |
GB9930591D0 (en) * | 1999-12-23 | 2000-02-16 | Univ London | Component for vaccine |
EP1255568A2 (en) * | 2000-02-18 | 2002-11-13 | Watson Pharmaceuticals, Inc. | Conjugates targeted to target receptors |
CA2774959C (en) | 2000-08-04 | 2016-05-31 | Dmi Biosciences, Inc. | Method of using diketopiperazines and composition containing them |
US7303907B2 (en) | 2001-01-08 | 2007-12-04 | Health Protection Agency | Degradation and detection of TSE infectivity |
NZ536054A (en) | 2002-04-09 | 2009-10-30 | Scripps Research Inst | Motif-grafted hybrid polypeptides and uses thereof |
EP1534746A2 (en) * | 2002-08-23 | 2005-06-01 | Copenhagen Biotech Assets APS | Composite peptide compounds for diagnosis and treatment of diseases caused by prion proteins |
CA2506037A1 (en) | 2002-11-14 | 2004-06-10 | Adherex Technologies, Inc. | Compounds and methods for modulating desmosomal and atypical cadherin-mediated cell adhesion |
US7354589B2 (en) * | 2003-01-16 | 2008-04-08 | The Wistar Institute | Multiple antigenic agents and methods for using the same |
PT2537524T (en) | 2003-05-15 | 2016-09-05 | Ampio Pharmaceuticals Inc | Treatment of t-cell mediated diseases |
US7740860B2 (en) | 2005-03-29 | 2010-06-22 | The Wistar Institute | Composition and method for preventing or treating a virus infection |
US7691396B2 (en) | 2005-06-15 | 2010-04-06 | The Ohio State University Research Foundation | Chimeric peptides comprising HER-2 B-cell epitopes and measles virus fusion protein T-cell epitopes |
KR100787393B1 (en) * | 2006-03-23 | 2007-12-21 | 학교법인 한림대학교 | 506 Cell-transducing fusion protein which comprising FK506 binding protein and protein transducing domain |
WO2009146320A1 (en) | 2008-05-27 | 2009-12-03 | Dmi Life Sciences, Inc. | Therapeutic methods and compounds |
US20120128684A1 (en) | 2008-08-25 | 2012-05-24 | Burnham Institute For Medical Research | Conserved Hemagglutinin Epitope, Antibodies to the Epitope and Methods of Use |
US20100234283A1 (en) | 2009-02-04 | 2010-09-16 | The Ohio State University Research Foundation | Immunogenic epitopes, peptidomimetics, and anti-peptide antibodies, and methods of their use |
CN102297968B (en) * | 2010-06-28 | 2013-10-30 | 程小星 | Kit for assisted diagnosis of tuberculosis |
EP2613786A4 (en) | 2010-09-07 | 2013-10-23 | Dmi Acquisition Corp | Treatment of diseases |
EP2765968A4 (en) | 2011-10-10 | 2015-01-21 | Ampio Pharmaceuticals Inc | Implantable medical devices with increased immune tolerance, and methods for making and implanting |
MY167804A (en) | 2011-10-10 | 2018-09-26 | Ampio Pharmaceuticals Inc | Treatment of degenerative joint disease |
JP6231484B2 (en) | 2011-10-28 | 2017-11-15 | アンピオ ファーマシューティカルズ,インコーポレイテッド | Rhinitis treatment |
CA2906864A1 (en) | 2013-03-15 | 2014-09-18 | Ampio Pharmaceuticals, Inc. | Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same |
TWI516272B (en) | 2013-06-05 | 2016-01-11 | 財團法人工業技術研究院 | Method and pharmaceutical composition for hair growth |
CN104231048B (en) * | 2013-06-05 | 2017-05-24 | 财团法人工业技术研究院 | Hair growth peptide and pharmaceutical composition |
JP6723222B2 (en) | 2014-08-18 | 2020-07-15 | アンピオ ファーマシューティカルズ,インコーポレイテッド | Treatment of joint pathology |
EP3310375A4 (en) | 2015-06-22 | 2019-02-20 | Ampio Pharmaceuticals, Inc. | Use of low molecular weight fractions of human serum albumin in treating diseases |
KR102653567B1 (en) * | 2017-03-28 | 2024-04-02 | 오하이오 스테이트 이노베이션 파운데이션 | Human PD1 peptide vaccine and uses thereof |
CN112851755B (en) * | 2021-01-13 | 2023-09-01 | 中国人民解放军军事科学院军事医学研究院 | Linear lipopeptide compound and preparation method and application thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2217319A (en) * | 1988-04-19 | 1989-10-25 | Synpharm Ltd | Racemic and optically active fatty amino acids, their homo- abd hetero-oligomers and conjugates, the process of their production, their pharmaceutical composi |
GB9215780D0 (en) * | 1992-07-24 | 1992-09-09 | Univ London Pharmacy | Peptide compounds |
US5674977A (en) * | 1993-02-05 | 1997-10-07 | The Ontario Cancer Institute | Branched synthetic peptide conjugate |
CA2169284A1 (en) * | 1993-08-11 | 1995-02-16 | Philip E. Dawson | Template assembled synthetic protein |
GB2282813A (en) * | 1993-10-15 | 1995-04-19 | Merck & Co Inc | Annular antigen scaffolds comprising thioether linkages |
DE69518838T2 (en) * | 1994-05-18 | 2001-05-03 | Protein Engineering Network Of | HETERODIME COMPOSITION OF IMMUNOGENIC POLYPEPTIDES AND METHOD FOR THE USE THEREOF |
-
1997
- 1997-04-03 WO PCT/DK1997/000146 patent/WO1997038011A1/en not_active Application Discontinuation
- 1997-04-03 NZ NZ331596A patent/NZ331596A/en unknown
- 1997-04-03 JP JP09535761A patent/JP2001502658A/en not_active Withdrawn
- 1997-04-03 CA CA002251464A patent/CA2251464A1/en not_active Abandoned
- 1997-04-03 CN CN97193489A patent/CN1215404A/en active Pending
- 1997-04-03 KR KR1019980708186A patent/KR20000005429A/en not_active Application Discontinuation
- 1997-04-03 AU AU25679/97A patent/AU704502B2/en not_active Ceased
- 1997-04-03 HU HU9901254A patent/HUP9901254A3/en unknown
- 1997-04-03 EP EP97917281A patent/EP0896582A1/en not_active Withdrawn
-
1998
- 1998-10-02 NO NO984644A patent/NO984644L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2251464A1 (en) | 1997-10-16 |
HUP9901254A3 (en) | 2001-10-29 |
EP0896582A1 (en) | 1999-02-17 |
AU704502B2 (en) | 1999-04-22 |
WO1997038011A1 (en) | 1997-10-16 |
AU2567997A (en) | 1997-10-29 |
HUP9901254A2 (en) | 1999-07-28 |
KR20000005429A (en) | 2000-01-25 |
NO984644L (en) | 1998-12-03 |
NZ331596A (en) | 1999-07-29 |
JP2001502658A (en) | 2001-02-27 |
CN1215404A (en) | 1999-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO984644D0 (en) | Non-dendritic spine peptide carrier | |
DE69728833D1 (en) | card holder | |
NO985680D0 (en) | peptide | |
DE29718912U1 (en) | Folder | |
NO983849D0 (en) | peptide | |
DE29719348U1 (en) | Folder | |
TR199701666A3 (en) | Proteins | |
DE29717020U1 (en) | Carrier bag | |
DE69707199T2 (en) | document holder | |
DE69711624T2 (en) | CARRIER | |
DE29602079U1 (en) | folder | |
EP1004666A4 (en) | Protein having pdz domain sequence | |
DE29606286U1 (en) | Information carrier | |
DE29606126U1 (en) | Offer folder | |
DE29608372U1 (en) | Carrier insert | |
KR970055231U (en) | Clip | |
DE29616765U1 (en) | Carrier system | |
DE29616002U1 (en) | Folder | |
DE29616214U1 (en) | carrier | |
KR970051486U (en) | carrier | |
KR980002751U (en) | Carrier Carrier | |
DE29609098U1 (en) | Carrier insert | |
KR970061068U (en) | Album | |
KR970051222U (en) | Clip | |
KR970052907U (en) | Clip |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |